Trial intelligence / Profile preview

Suboxone versus methadone for opioid use disorder in adults with chronic non-cancer pain

NL-OMON60438Phase 4Recruiting

Sponsor
Radboud University Medical Center
Start
May 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of Suboxone and methadone in opioid use disorder (OUD) and Chronic non-cancer pain (CNCP) (2 arms), sponsored by Radboud University Medical Center. Started May 2022; status: recruiting.

02

Drugs

Suboxonemethadone
03

Conditions

opioid use disorder (OUD)Chronic non-cancer pain (CNCP)

Beyond the preview

Go deeper on NL-OMON60438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON60438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call